Patents Represented by Attorney, Agent or Law Firm Law Offices of Wayne A. Keown
  • Patent number: 6440409
    Abstract: The invention features a method of selectively killing a first microorganism. The method includes: (i) contacting the first microorganism with a second microorganism that has a microcidal compound; and (ii) allowing the first microorganism and the second microorganism to undergo fusion, whereby the microcidal compound is delivered into and kills the microorganism that forms following the fusion.
    Type: Grant
    Filed: April 16, 1999
    Date of Patent: August 27, 2002
    Assignee: Whitehead Institute for Biomedical Research
    Inventors: G. Todd Milne, Gerald R. Fink
  • Patent number: 6426334
    Abstract: The invention provides new methods for modulating specific CMI-inducing cytokines in vivo. Such new methods result in stimulation of the cytokines IL-6, IL-12 MIP-1&bgr; and MCP without substantially inducing undesired cytokines. The methods according to the invention are based upon administration of oligonucleotides containing particular structural motifs which lead to specific cytokine induction.
    Type: Grant
    Filed: April 30, 1997
    Date of Patent: July 30, 2002
    Assignee: Hybridon, Inc.
    Inventors: Sudhir Agrawal, Qiuyan Zhao
  • Patent number: 6416769
    Abstract: Cosmetic compositions for topical use that comprise an exfoliating enzyme for use in removal of at least a portion of the dead skin cells from the outer layer of skin, in conjunction with one or more botanicals, the delivery of which to subsurface layers and cells thereof of the skin is enhanced by the presence of the exfoliating enzyme. These compositions, including gels, lotions, and creams, are gentle, non-irritating and enhance the penetration of biological additives into the subsurface skin layers relative to currently commercially available compositions.
    Type: Grant
    Filed: March 3, 2000
    Date of Patent: July 9, 2002
    Assignee: Australian Importers, Ltd.
    Inventor: Jacob Vromen